3,6-Difluoropyrazine-2-carboxamide (CAS No. 356783-29-4) or 3,6-Difluoropyrazine-2-carboxamide is an intermediate in the synthesis of Favipiravir that is that the atom labeled analog of Favipiravir. Favipiravir is employed for the treatment of advanced Ebola virus infection in a small animal model. Favipiravir suppressed the replication of Zaire Ebola virus and prevented a deadly outcome in 100% of the animals.
“Sci-Hub, a Practical and Step-Economic Route to Favipiravir, 10.1007/S11696-017-0208-6.” Hkvisa.net, 2017, sci-hub.hkvisa.net/10.1007/s11696-017-0208-6.